Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine...
BioNTech
Three doses of Sinovac's CoronaVac Covid-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of...
Paris: Three doses of a Covid vaccine may not be able to curb the rapid spread of the highly transmissible...
Two Singapore residents may have caught the omicron variant even after receiving Covid-19 booster shots, in cases which may shed...
FRANKFURT: Germany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, its...
WASHINGTON: Pfizer and BioNTech said on Monday their Covid-19 vaccine remained 100 percent effective in children 12 to 15 years...
WASHINGTON: Pfizer asked the US government Thursday to allow use of its Covid-19 vaccine in children ages 5 to 11...
Washington: The world will return to normal life as COVID-19 will end in a year, Pfizer CEO Albert Bourla has...
London: US drugmaker Pfizer wrongly assumed that the coronavirus outbreak would be quickly contained and thus declined the offer made...
BEIJING: The Delta variant is challenging China's costly strategy of isolating cities, prompting warnings that Chinese leaders who were confident...